Association of the I1307K APC mutation with hereditary and sporadic breast/ovarian cancer: More questions than answers

R. Gershoni-Baruch, Y. Patael, Dagan, A. Figer, L. Kasinetz, E. Kadouri, R. Bruchim Bar Sade, E. Friedman*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

20 Scopus citations

Abstract

The frequency of the APC I1307K mutation and its association with disease pattern was examined in 996 Ashkenazi women consisting of individuals with either sporadic (n = 382) or hereditary (n = 143) breast and/or ovarian cancer; asymptomatic BRCA1/2 mutation carriers (185delAG, 5382insC and 6174delT) (n = 53) and healthy controls (n = 418). The I1307K allele was equally distributed among women with sporadic (17/382; 4.6%) and inherited (10/143; 7%) breast and/or ovarian cancer irrespective of their being diagnosed before or after 42 years of age and among asymptomatic (7/53; 13.2%) and cancer manifesting BRCA1/2 carriers (10/143; 7%). Taken together, the prevalence of the I1307K allele was significantly higher in BRCA1/2 carriers compared to non-BRCA1/2 carriers (17/196; 8.7% and 40/800, 5%; respectively). The high prevalence of the I1307K allele among BRCA1/2 carriers is not associated with increased cancer risk but seems to be genetically connected because of Jewish ancestry. (C) 2000 Cancer Research Campaign.

Original languageEnglish
Pages (from-to)153-155
Number of pages3
JournalBritish Journal of Cancer
Volume83
Issue number2
DOIs
StatePublished - 2000

Funding

FundersFunder number
Israel Cancer Research Fund
Mechanics Electronics Computer Corporation

    Keywords

    • APC
    • BRCA1
    • BRCA2
    • Breast cancer
    • I1307K polymorphism
    • Ovarian cancer

    Fingerprint

    Dive into the research topics of 'Association of the I1307K APC mutation with hereditary and sporadic breast/ovarian cancer: More questions than answers'. Together they form a unique fingerprint.

    Cite this